BeOne Medicines (ONC) Current Leases (2019 - 2026)

BeOne Medicines (ONC) has 8 years of Current Leases data on file, last reported at $20.6 million in Q1 2026.

• On a quarterly basis, Current Leases rose 12.46% year-over-year to $20.6 million in Q1 2026; TTM through Mar 2026 was $20.6 million, a 12.46% increase from a year earlier, with the FY2025 full-year figure at $20.7 million, up 17.76% from the prior year.
• Current Leases for Q1 2026 stood at $20.6 million, down from $20.7 million in the prior quarter.
• Over the last five years, Current Leases for ONC reached as high as $24.8 million in Q2 2022 and fell as low as $15.7 million in Q3 2025.
• Historically, Current Leases has averaged $20.8 million across 5 years, with a median of $20.7 million in 2025.
• Across the five-year window, Current Leases jumped 63.61% in 2022 and slipped 24.89% in 2024, its largest moves.
• Year by year, Current Leases stood at $24.0 million in 2022, then slipped by 8.7% to $22.0 million in 2023, then slipped by 19.93% to $17.6 million in 2024, then rose by 17.76% to $20.7 million in 2025, then declined by 0.55% to $20.6 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $20.6 million in Q1 2026, $20.7 million in Q4 2025, and $15.7 million in Q3 2025.